Details for Patent: 5,342,625
✉ Email this page to a colleague
Summary for Patent: 5,342,625
Title: | Pharmaceutical compositions comprising cyclosporins |
Abstract: | Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms. |
Inventor(s): | Hauer; Birgit (Lahr, DE), Meinzer; Armin (Freiburg/Munzingen, DE), Posanski; Ulrich (Freiburg, DE), Richter; Friedrich (Schonbuhl-Urtenen, CH) |
Assignee: | Sandoz Ltd. (Basel, CH) |
Application Number: | 07/990,734 |
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; | More… ↓ |
Drugs Protected by US Patent 5,342,625
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,342,625
International Family Members for US Patent 5,342,625
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 403435 | ⤷ Subscribe | |||
Austria | A214289 | ⤷ Subscribe | |||
Australia | 4140089 | ⤷ Subscribe | |||
Australia | 627220 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |